Boron-containing nucleosides as tools for boron-neutron capture therapy

Area of Science:

• Oncology
• Radiotherapy
• Molecular Biology

Background:

• Cancer therapy requires novel approaches as many deadly tumors remain untreatable.
• Boron neutron capture therapy (BNCT) is a promising approach utilizing boron-10 isotopes and neutron irradiation.
• Effective boron delivery and accumulation in cancer cells are critical challenges for BNCT clinical application.

Purpose of the Study:

• To review the synthesis of boron-containing nucleosides.
• To explore the application of these compounds in BNCT.
• To focus on the potential incorporation of boron into cancer cell genomic DNA.

Main Methods:

• Review of existing literature on boron-containing nucleoside synthesis.
• Analysis of studies on BNCT applications.
• Discussion of strategies for boron nucleotide incorporation into DNA.

Main Results:

• Progress has been made in synthesizing various boron-containing nucleosides.
• These compounds show potential for targeted boron delivery in BNCT.
• Incorporation into genomic DNA could significantly enhance BNCT efficacy.

Conclusions:

• Boron-containing nucleosides offer a promising strategy to improve BNCT.
• Targeting DNA with boron nucleotides may overcome current limitations in boron delivery.
• Further research into DNA incorporation is crucial for advancing BNCT.